SPI develops and delivers therapeutics enabling doctors and patients to prevent and treat hearing loss... Read more
SPI develops and delivers therapeutics enabling doctors and patients to prevent and treat hearing loss... Read more
News
Jul 08, 2025
StreetInsider
Press Release: Sound Pharmaceuticals : Sound Pharma to Present at Upcoming Life Sciences Industry Conferences
Apr 08, 2025
Yahoo
Sound Pharmaceuticals: Sound Pharma to Present at Upcoming Life Science Investor Conferences
Feb 18, 2025
StreetInsider
Press Release: Sound Pharmaceuticals : Sound Pharma to Present SPI-1005 Preclinical and Clinical Hearing Loss and Tinnitus Data at the Defense Health Agency Hearing Center of Excellence Symposia and ARO MWM
Dec 10, 2024
StreetInsider
Press Release: Sound Pharmaceuticals : Sound Pharma Announces Positive Phase 3 Results for the Treatment of Meniere's Disease with SPI-1005
Aug 19, 2024
Pharamceutical Technology
Sound Pharmaceuticals: Sound Pharmaceuticals plans to stick with WuXi amid BIOSECURE Act rumblings
Aug 01, 2024
Clinical Trials Arena
Sound Pharmaceuticals: Sound Pharmaceuticals concludes Phase III Meniere's disease therapy trial
May 20, 2024
FinanzNachrichten
Sound Pharmaceuticals: Sound Pharmaceuticals' IND Involving Cochlear Implantation Allowed by the FDA
May 03, 2023
StreetInsider
Press Release: Sound Pharmaceuticals : Sound Pharma completes enrollment in pivotal Phase 3 clinical trial of SPI-1005 for the treatment of Meniere's disease involving hearing loss, tinnitus, and dizziness.
Jul 28, 2022
PR Newswire
Press Release: Sound Pharmaceuticals : Sound Pharma initiates enrollment in pivotal Phase 3 clinical trial of SPI-1005 for the treatment of hearing loss and tinnitus in Meniere's disease
May 12, 2022
Pharamceutical Technology
Sound Pharmaceuticals: Sound Pharmaceuticals gets NIH grant for Covid-19 therapy development
